The Lovesac Company (LOVE) Balance Sheet
As of 2026-08-02 (10-Q), The Lovesac Company (LOVE) reported total assets of $539.0M, total liabilities of $329.0M and shareholders' equity of $210.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $68.8M.
Source: SEC EDGAR filings · figures as of 2026-08-02 · read by EquiReason
LOVEThe Lovesac CompanyFollow LOVE — free
—
Price chart with a free account
- Market cap
- 223.4M
- P/E TTM
- 12.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Dec, in 46 days
| Line | FY2019 Feb 19 | FY2020 Feb 20 | FY2021 Jan 21 | FY2022 Jan 22 | FY2023 Jan 23 | FY2024 Feb 24 | FY2025 Feb 25 | FY2026 Feb 26 | Latest Aug 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 49.1 | 48.5 | 78.3 | 92.4 | 43.5 | 87.0 | 83.7 | 101.9 | 68.8 | |
| Receivables | 4.0 | 7.2 | 4.5 | 8.5 | 9.1 | 13.5 | 16.8 | 11.7 | 16.7 | |
| Inventory | — | 1.1 | 3.2 | — | — | — | — | — | — | |
| Current assets | 85.1 | 100.2 | 143.4 | 221.7 | 187.7 | 214.4 | 246.6 | 236.6 | 238.8 | |
| Total assets | 105.0 | 125.7 | 171.0 | 369.1 | 408.6 | 482.2 | 532.3 | 534.7 | 539.0 | |
| Current liabilities | 24.6 | 32.4 | 56.3 | 114.7 | 82.0 | 106.4 | 155.1 | 147.1 | 162.2 | |
| Long-term debt | — | — | 78.0 | — | — | — | — | — | — | |
| Short-term debt | — | — | 14.0 | — | — | — | — | — | — | |
| Total liabilities | 26.2 | 35.5 | 63.1 | 211.3 | 215.5 | 264.7 | 315.9 | 316.0 | 329.0 | |
| Shareholders' equity | 78.8 | 90.2 | 107.9 | 157.8 | 193.1 | 217.5 | 216.4 | 218.7 | 210.0 |
USD millions · SEC XBRL
The Lovesac Company — questions
- How much cash does The Lovesac Company have?
- $68.8M in cash and cash equivalents as of 2026-08-02.
- What are The Lovesac Company's total assets?
- $539.0M as of 2026-08-02.
- What is The Lovesac Company's shareholders' equity?
- $210.0M as of 2026-08-02.
Every figure on this page comes from The Lovesac Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.